What is Novanta's annual revenue?
Novanta Inc. generates substantial annual revenues driven by its specialized position as a trusted technology partner delivering mission-critical components, medical technology solutions, and advanced precision motion and vision products to original equipment manufacturers. Financial reports indicate that the corporation brings in annual revenues scaling reliably over eight hundred million to nearly one billion US dollars, fluctuating based on demand cycles in healthcare, life sciences, and advanced industrial automation sectors across global markets.
Related FAQs
Wall Street analyst consensus for Novanta (ticker NOVT) leans heavily toward a buy recommendation, driven by its strong positioning in advanced photonics, precision motion, and medical technology equipment.
Novanta maintains a high price-to-earnings ratio that reflects strong investor confidence, premium market valuation multiples, and expectations for robust future earnings growth within the specialized medical and technology manufacturing sectors.
NOVT represents the stock ticker symbol for Novanta Inc., an innovative multinational technology enterprise focused on mission-critical subsystems and components for medical and advanced industrial original equipment manufacturers.
NOVT is the official stock ticker symbol for Novanta Inc., a prominent global technology enterprise publicly traded on the Nasdaq stock exchange.
Nucor Corporation is the largest steel producer in the United States and North America's foremost sustainable steel recycling and manufacturing enterprise, utilizing advanced electric arc furnaces to produce steel products.
Novanta fosters a high-performance corporate culture centered on innovation, collaboration, integrity, and continuous technological problem-solving.
Novanta Inc., traded under the ticker symbol NOVT, belongs to the Electronic Technology sector.
Novanta Inc. (NASDAQ: NOVT) trades at a market price of approximately $142.55 per share.
Novanta Inc.
Novanta's annual corporate revenue streams reflect strong commercial demand for its three primary operating business segments: Medical Solutions, Precision Motion, and Vision Technologies.
Analysts tracking specialized corporate entities or technology firms trading under tickers like Novt maintain a focused evaluation on operational milestone execution, financial liquidity, and sector demand trends.
Novanta Inc. manufactures precision photonics, vision, and precise motion control components utilized in advanced medical and industrial original equipment manufacturing applications.
Novanta Inc.
Equity research analysts covering Novanta Inc., which trades on the Nasdaq stock exchange under the ticker symbol NOVT, maintain a generally positive long-term consensus outlook.
For the most recent dividend cycle in 2026, Nutrien (NTR) declared a dividend of $0.55 per share. The company traded ex-dividend on June 30, 2026, meaning that shareholders of record as of that date were entitled to receive the payment.
Novanta Inc.
Novanta is widely regarded as an exceptional, high-quality technology enterprise specializing in proprietary trusted photonics, precision motion, and vision technologies for medical and advanced industrial original equipment manufacturers.
Novanta Inc. is a fully established, publicly traded corporate entity listed on the NASDAQ global select market under a designated ticker symbol.